International journal of dermatology, cilt.54, sa.5, ss.594-9, 2015 (SCI-Expanded)
BackgroundTumor necrosis factor-alpha (TNF-) antagonist treatment is associated with 1.6 to 27 times higher risk of tuberculosis (TB).